ERADICATE Hp - Treating Helicobacter Pylori With RHB-105
Public ClinicalTrials.gov record NCT01980095. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Placebo-Controlled Phase 3 Study to Assess the Safety and Efficacy of RHB-105 in the Treatment of Confirmed Helicobacter Pylori (H. Pylori) Infection in Non-investigated Dyspepsia Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The "test and treat" strategy for treating dyspeptic patients who are H. pylori positive is rapidly becoming the standard of care. This study will test the effectiveness of RHB-105, a new triple therapy to treat H. pylori infection in dyspeptic patients.
Study identification
- NCT ID
- NCT01980095
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 119 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2013 (Type not available)
- Primary completion
- Jun 2015 (Actual)
- Completion
- Aug 2015 (Actual)
- Last update posted
- Sep 24, 2019
2013 – 2015
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anaheim Clinical Trials, LLC | Anaheim | California | 92801 | — |
| Anaheim Clinical Trials | Anaheim | California | 92801 | — |
| Catalina Research Institute | Chino | California | 91710 | — |
| Jupiter Research, Inc. | Jupiter | Florida | 33458 | — |
| Columbus Regional Research Institute | Columbus | Georgia | 31904 | — |
| MedPharmics | Metairie | Louisiana | 70006 | — |
| Investigative Clinical Research | Annapolis | Maryland | 41401 | — |
| MGG Group Co. Chevy Chase Clinical Research | Chevy Chase | Maryland | 20815 | — |
| Detroit Clinical Research Center | Farmington Hills | Michigan | 48334 | — |
| Office of Dr. Stephen Miller, MD | Las Vegas | Nevada | 89144 | — |
| Peters Medical Research | High Point | North Carolina | 27262 | — |
| Wake Research Associates | Raleigh | North Carolina | 27612 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01980095, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 24, 2019 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01980095 live on ClinicalTrials.gov.